Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Want to see TSE:NEVI full AI Analyst Report?
NEVI Stock Chart & Stats
C$0.07
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.07
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.10
Previous CloseN/A
Volume0.00
Average Volume (3M)55.49K
Market Cap
C$991.57K
Enterprise ValueC$1.29M
Total Cash (Recent Filing)C$102.17K
Total Debt (Recent Filing)C$244.21K
Price to Earnings (P/E)―
Beta2.11
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding39,662,727
10 Day Avg. Volume84,932
30 Day Avg. Volume55,489
Financial Highlights & Ratios
PEG Ratio0.26
Price to Book (P/B)2.05
Price to Sales (P/S)1.17
P/FCF Ratio31.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue Growth TrendSustained acceleration in top-line growth indicates improving market traction and product adoption. If revenue expansion continues, it supports operating leverage, reduces dependence on external funding, and creates a clearer path to durable profitability over the next 2–6 months.
Cash Flow ImprovementTransitioning to positive operating and free cash flow demonstrates improving cash conversion and expense control. Stronger internal cash generation lowers short-term refinancing risk and gives management flexibility to invest in growth or stabilize margins without immediate external capital.
Lower LeverageMeaningfully reduced leverage improves financial resilience and lowers fixed financial costs, giving the company more flexibility to absorb near-term losses. A stronger balance sheet supports longer-term investments in distribution or product improvements without over-reliance on debt.
Bears Say
Ongoing Net LossesPersisting negative net margins mean the company remains dependent on improving margins or external capital to reach sustainable profitability. Continued losses erode equity and can force dilution or constrain strategic initiatives if the improvement trajectory stalls.
Sharp Gross Margin DeclineA dramatic drop in gross margin signals structural pressure from costs, pricing, or mix changes. Such volatility undermines margin sustainability; without clear remediation (cost cuts or pricing recovery), profitability gains at the operating and net level may be fragile.
Small Scale And Cash FragilityVery small headcount and modest cash generation limit operational scale, product development speed, and distribution reach. Combined with prior years' negative cash flow, the company may need external funding if revenue or margin trends reverse, increasing execution risk.
Pascal Biosciences Inc News
NEVI FAQ
What was Pascal Biosciences Inc’s price range in the past 12 months?
Pascal Biosciences Inc lowest stock price was C$0.03 and its highest was C$0.10 in the past 12 months.
What is Pascal Biosciences Inc’s market cap?
Pascal Biosciences Inc’s market cap is C$991.57K.
When is Pascal Biosciences Inc’s upcoming earnings report date?
Pascal Biosciences Inc’s upcoming earnings report date is Jul 23, 2026 which is in 39 days.
How were Pascal Biosciences Inc’s earnings last quarter?
Currently, no data Available
Is Pascal Biosciences Inc overvalued?
According to Wall Street analysts Pascal Biosciences Inc’s price is currently Overvalued.
Does Pascal Biosciences Inc pay dividends?
Pascal Biosciences Inc does not currently pay dividends.
What is Pascal Biosciences Inc’s EPS estimate?
Pascal Biosciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pascal Biosciences Inc have?
Pascal Biosciences Inc has 39,662,727 shares outstanding.
What happened to Pascal Biosciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pascal Biosciences Inc?
Currently, no hedge funds are holding shares in TSE:NEVI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Pascal Biosciences Inc
Based in Seattle, Washington, Nevis Brands Inc. is engaged in developing and commercializing cannabis products across the United States. Its signature offering is Major, a popular cannabis-infused beverage. The company adopted its current name, Nevis Brands Inc., in June 2023, having previously been known as Pascal Biosciences Inc.
Technical Analysis
TAAT Global Alternatives
―
West Island Brands Inc
―
Modern Meat
―
Lifeist Wellness
―
Element Nutritional Sciences Inc
―
Options Prices
Currently, No data available
---